Banque Pictet & Cie’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $34.9M | Sell |
186,686
-9,124
| -5% | -$1.72M | 0.22% | 48 |
|
|
2026
Q1 | $37.9M | Buy |
+195,810
| New | +$37.8M | 0.27% | 47 |
|
|
2023
Q4 | – | Sell |
-627
| Closed | -$84.9K | – | 364 |
|
|
2023
Q3 | $84.9K | Sell |
627
-72,009
| -99% | -$9.84M | ﹤0.01% | 428 |
|
|
2023
Q2 | $10.4M | Sell |
72,636
-3,278
| -4% | -$482K | 0.09% | 107 |
|
|
2023
Q1 | $10.5M | Sell |
75,914
-15,230
| -17% | -$2.05M | 0.1% | 99 |
|
|
2022
Q4 | $12.4M | Sell |
91,144
-3,145
| -3% | -$394K | 0.13% | 90 |
|
|
2022
Q3 | $10.3M | Sell |
94,289
-653
| -0.7% | -$82.8K | 0.11% | 98 |
|
|
2022
Q2 | $12.5K | Sell |
94,942
-4,277
| -4% | -$561K | 0.12% | 88 |
|
|
2022
Q1 | $13.2M | Sell |
99,219
-865
| -0.9% | -$104K | 0.1% | 93 |
|
|
2021
Q4 | $11.7M | Sell |
100,084
-1,695
| -2% | -$199K | 0.09% | 116 |
|
|
2021
Q3 | $12.2M | Sell |
101,779
-15,816
| -13% | -$1.84M | 0.13% | 86 |
|
|
2021
Q2 | $28.2M | Buy |
117,595
+1,371
| +1% | +$150K | 0.31% | 46 |
|
|
2021
Q1 | $23.2M | Buy |
116,224
+2,455
| +2% | +$247K | 0.3% | 48 |
|
|
2020
Q4 | $22.8M | Buy |
113,769
+1,314
| +1% | +$139K | 0.31% | 49 |
|
|
2020
Q3 | $24.6M | Sell |
112,455
-2,029
| -2% | -$226K | 0.37% | 38 |
|
|
2020
Q2 | $23.8M | Sell |
114,484
-1,362
| -1% | -$141K | 0.4% | 38 |
|
|
2020
Q1 | $20.7M | Sell |
115,846
-939
| -0.8% | -$88.4K | 0.43% | 33 |
|
|
2019
Q4 | $23.5M | Buy |
116,785
+679
| +0.6% | +$63.9K | 0.41% | 39 |
|
|
2019
Q3 | $20.8M | Buy |
116,106
+8,013
| +7% | +$695K | 0.39% | 41 |
|
|
2019
Q2 | $17.7M | Sell |
108,093
-12,734
| -11% | -$998K | 0.33% | 46 |
|
|
2019
Q1 | $19.3M | Sell |
120,827
-17,157
| -12% | -$1.35M | 0.37% | 45 |
|
|
2018
Q4 | $20.6M | Sell |
137,984
-2,041
| -1% | -$159K | 0.42% | 38 |
|
|
2018
Q3 | $21.8M | Buy |
140,025
+1,465
| +1% | +$111K | 0.4% | 44 |
|
|
2018
Q2 | $19.2M | Sell |
138,560
-1,282
| -0.9% | -$92.2K | 0.38% | 48 |
|
|
2018
Q1 | $19.2M | Buy |
139,842
+6,852
| +5% | +$475K | 0.4% | 47 |
|
|
2017
Q4 | $18.4M | Sell |
132,990
-960
| -0.7% | -$64.7K | 0.37% | 49 |
|
|
2017
Q3 | $17.8M | Sell |
133,950
-774
| -0.6% | -$48.9K | 0.4% | 50 |
|
|
2017
Q2 | $18M | Sell |
134,724
-55
| -0% | -$3.59K | 0.43% | 49 |
|
|
2017
Q1 | $16.6M | Sell |
134,779
-2,760
| -2% | -$161K | 0.41% | 49 |
|
|
2016
Q4 | $7.51M | Sell |
137,539
-6,400
| -4% | -$363K | 0.19% | 81 |
|
|
2016
Q3 | $9.46M | Buy |
143,939
+3,224
| +2% | +$211K | 0.24% | 72 |
|
|
2016
Q2 | $8.5M | Buy |
+140,715
| New | +$8.17M | 0.23% | 69 |
|
Other funds holding AZN
EPGL
RG
SAM
CDDEC
MGP
Banque Pictet & Cie's AZN Position: Q2 2026 in Review
Banque Pictet & Cie reduced its AstraZeneca (AZN) stake by 4.7% in Q2 2026, selling an estimated $1.72M and leaving 186,686 shares worth $34.9M. The position accounts for 0.22% of the portfolio, ranked #48.
Banque Pictet & Cie first reported a position in AZN in Q2 2016 and has held it in 32 quarters since. The position peaked at $37.9M in Q1 2026. 977 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Banque Pictet & Cie held 186,686 shares of AstraZeneca worth $34.9M as of Q2 2026.
- Banque Pictet & Cie sold 9,124 AstraZeneca shares in Q2 2026, an estimated $1.72M.
- AstraZeneca made up 0.22% of Banque Pictet & Cie's portfolio in Q2 2026, its #48 holding.
- Banque Pictet & Cie first reported a position in AstraZeneca in Q2 2016 and has held it in 32 quarters since.
- Banque Pictet & Cie's AstraZeneca position peaked at $37.9M in Q1 2026.
- 977 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.